Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment studyMartin John Connor, Mesfin G Genie, Michael Gonzalez, Naveed Sarwar, Kamalram Thippu Jayaprakash, Gail Horan, Feargus Hosking-Jervis, Natalia Klimowska-Nassar, Johanna Sukumar, Tzveta Pokrovska, Dolan Basak, Angus Robinson, Mark Beresford, Bhavan Rai, Stephen MangarSee the full list of authors
18 November 2021
ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocolKarl-Friedrich Kowalewski, Marie Angela Sidoti Abate, Manuel Neuberger, Marietta Kirchner, Regina Krisam, Luisa Egen, Caelan Max Haney, Fabian Siegel, Maurice-Stephan Michel, Patrick Honeck, Philipp Nuhn, Niklas Westhoff, Maximilian Christian Kriegmair
3 November 2021
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRITeresa Marsden, Derek J Lomas, Neil McCartan, Joanna Hadley, Steve Tuck, Louise Brown, Anna Haire, Charlotte Louise Moss, Saran Green, Mieke Van Hemelrijck, Ton Coolen, Aida Santaolalla, Elizabeth Isaac, Giorgio Brembilla, Douglas KopckeSee the full list of authors
30 September 2021
Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing non-cardiac surgery: a retrospective cohort analysisYong-Zhong Tang, Pingping Zeng, Yan Liao, Zheng Qin, Hao Zhang, Bo Li, Wen Ouyang, Dan Li
25 August 2021
Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analysesNikolaos Pyrgidis, Ioannis Mykoniatis, Anna-Bettina Haidich, Maria Tirta, Persefoni Talimtzi, Dimitrios Kalyvianakis, Andreas Ouranidis, Dimitrios Hatzichristou
24 August 2021
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study designStephen J Freedland, Ugo De Giorgi, Martin Gleave, Brad Rosbrook, Qi Shen, Jennifer Sugg, Gabriel P Haas, Neal D Shore
12 August 2021
Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysisChengzhuo Li, Didi Han, Qiao Huang, Fengshuo Xu, Shuai Zheng, Xiang Li, Fanfan Zhao, Xiaojie Feng, Jun Lyu
19 July 2021
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomyNaomi Morka, Benjamin S Simpson, Rhys Ball, Alex Freeman, Alex Kirkham, Daniel Kelly, Hayley C Whitaker, Mark Emberton, Joseph M Norris
5 May 2021
Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trialGautier Müllhaupt, Sabine Güsewell, Hans-Peter Schmid, Valentin Zumstein, Patrick Betschart, Daniel S Engeler, Dominik Abt
3 May 2021
Short-term morbidity and mortality following radical cystectomy: a systematic reviewSophia Liff Maibom, Ulla Nordström Joensen, Alicia Martin Poulsen, Henrik Kehlet, Klaus Brasso, Martin Andreas Røder
14 April 2021